C&S Partners advises Dr. Lal PathLabs on acquiring 70% stake in SN Genelab
Dr. Lal PathLabs Limited has acquired a 70% stake in SN Genelab Private Limited. C&S Partners advised Dr. Lal PathLabs on this acquisition.
SectorIndustrials
Sources
Open in the live tracker →Related deals
- Cyril Amarchand Mangaldas advised OnEMI Technology Solutions on ₹832 crore fundraise4 Nov 2026 · ₹832 cr
- Kanga & Co acts on Jai Parvati Forge ₹300 crore+ proposed IPO4 Nov 2026 · ₹300 cr
- JM Financial Limited: Press Release4 Nov 2026 · ₹1,056 cr
- Narayana Hrudayalaya Ltd.: Demerger4 Nov 2026
- Max Estates Limited: Acquisition4 Nov 2026
- Krishna Institute of Medical Sciences Limited: Amalgamation/Merger4 Nov 2026